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Abstract
Background: The nature of the association between ghrelin, an orexigenic hormone produced mainly in the
stomach, and Helicobacter pylori (H pylori), a bacterium that colonises the stomach, is still controversial. We
examined available evidence to determine whether an association exists between the two; and if one exists, in
what direction.
Methods: We reviewed original English language studies on humans reporting circulating ghrelin levels in H pylori
infected and un-infected participants; and circulating ghrelin levels before and after H pylori eradication. Meta-
analyses were conducted for eligible studies by combining study specific estimates using the inverse variance
method with weighted average for continuous outcomes in a random effects model.
Results: Seventeen out of 27 papers that reported ghrelin levels in H pylori positive and negative subjects found
lower circulating ghrelin levels in H pylori positive subjects; while 10 found no difference. A meta-analysis of 19
studies with a total of 1801 participants showed a significantly higher circulating ghrelin concentration in H pylori
negative participants than in H pylori positive participants (Effect estimate (95%CI) = -0.48 (-0.60, -0.36)). However,
eradicating H pylori did not have any significant effect on circulating ghrelin levels (Effect estimate (95% CI) = 0.08
(-0.33, 0.16); Test for overall effect: Z = 0.67 (P = 0.5)).
Conclusions: We conclude that circulating ghrelin levels are lower in H pylori infected people compared to those
not infected; but the relationship between circulating ghrelin and eradication of H pylori is more complex.
Background
The relationship between ghrelin, a 28-amino acid pep-
tide secreted primarily by the oxyntic cells of the sto-
mach [1] and involved in body mass regulation, and
Helicobacter pylori (H pylori), a bacterium that colonises
the stomach, has remained controversial. The first
report suggesting an association between the two was
that by Nwokolo et al [2] who examined the effect of
Hp y l o r ieradication on plasma ghrelin levels in 12
healthy adult male and female subjects. They reported
that eradicating Hp y l o r ifrom the subjects was asso-
ciated with an increase in plasma ghrelin levels. At
about the same time, Gockel et al [3] reported that
Hp y l o r ihad no effect on plasma ghrelin levels in a
study of 39 age- and BMI-matched H pylori positive and
negative women. Subsequently a number of other
papers, including animal studies, have explored this rela-
tionship [4-7]. A number of review articles have also
appeared exploring this relationship [8,9]; but none of
these has been conducted systematically.
Considering the putative role of ghrelin in body mass
regulation, understanding this association could help in
maximizing its benefits, and also provide further insight
into the physiology of appetite and body mass regula-
tion. The objective of this review is to examine available
evidence to determine whether or not a relationship
exists between ghrelin and H pylori infection; and where
one exist, to investigate the direction of the association.
Specifically, this review sets out to answer three ques-
tions: 1) Is H pylori infection associated with circulating
ghrelin levels? 2) what is the effect of eradicating
H pylori infection on circulating ghrelin levels?; and 3)
what is the effect of H pylori infection on ghrelin produ-
cing cells in the stomach?
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Literature search strategy and data extraction
A comprehensive search of the scientific literature
(Medline (OVID), OvidMedline (R) 1950 - October
W e e k2p l u sI n - p r o c e s s&N o n - i n d e x e dc i t a t i o n s ,
Embase (1980 to 2010 week 41), and ISI Web of Know-
ledge) was conducted using the search terms “ghrelin
AND helicobacter pylori“. The search was repeated sev-
eral times. The last search was conducted on October
29, 2010. Further searches were conducted using Google
scholar; while the bibliography of original and review
articles were searched for studies with ghrelin and heli-
cobacter pylori in their titles. Duplicate searches were
first removed; thereafter, the abstracts of retrieved arti-
cles were reviewed for relevance prior to accessing the
full paper. Only English-language primary studies on
h u m a n sw e r ei n c l u d e dp r o v i d e dt h a tt h ea u t h o r s
assessed at least one of the following: 1) compared cir-
culating ghrelin concentration in Hp y l o r ipositive and
negative subjects; 2) compared the effect of eradicating
Hp y l o r ion circulating ghrelin levels; or 3) compared
gastric ghrelin in H pylori positive and negative subjects
or changes in gastric ghrelin after Hp y l o r ieradication.
Letters in response to published articles, commentaries,
and editorials were excluded. Conference abstracts that
had not been published as full papers were included
where the full abstracts could be retrieved, provided that
such conference abstract contained enough information
for either the qualitative or the quantitative synthesis.
However, where a conference abstract has been pub-
lished as a full paper, the full paper was retrieved and
the conference proceeding excluded.
Efforts were made to contact authors of conference
abstracts whose full paper publications could not be traced
to inquire if the paper had been published as a full paper
and if not, to get further details about the study. Efforts
were also made to contact authors of papers where some
relevant information was missing to request for the miss-
ing information or for further clarifications. We contacted
18 authors [2,6,10-25]; but only nine authors [2,14,
18,21-26] responded and provided the needed informa-
tion. We were unable to contact one author [27].
We also attempted to group the papers reviewed by
study teams in other to assess the spread of the papers
reviewed. In deciding whether different papers were pub-
lished by the same research groups, similarity in author-
ship was examined. Where at least one author contributed
to different publications, those publications were deemed
to have emanated from the same research group.
Outcomes evaluated
Outcomes evaluated included: differences in circulating
ghrelin levels between Hp y l o r ipositive and negative
subjects; changes in circulating ghrelin concentration
after H pylori eradication; differences in ghrelin mRNA
between H pylori positive and negative subjects; changes
in ghrelin mRNA after Hp y l o r ieradication; differences
in ghrelin immunoreactive cells between Hp y l o r iposi-
tive and negative subjects; changes in ghrelin immunor-
eactive cells after cure; correlation between ghrelin
immunoreactive cells with severity of H pylori infection;
correlation between gastric and plasma ghrelin; correla-
tion between ghrelin mRNA and plasma ghrelin; and
correlation between cells and plasma ghrelin.
Data synthesis
The data extracted were classified into three classes:
1) data comparing circulating ghrelin concentration in
H pylori positive and negative subjects; 2) data compar-
ing the circulating ghrelin concentration before and
after Hp y l o r ieradication; and 3) data assessing any of
the gastric ghrelin parameters. Each of these classes was
supposed to answer a specific question (Table 1). The
variables were re-coded in forms that would make ana-
lysis easier (Table 2). Table 3 lists the papers excluded
from the review and the reasons for their exclusion.
Statistical analysis
Simple proportions were used to determine the fre-
quency of occurrence of each categorical variable consid-
ered; and association between different variables assessed
using Fisher’se x a c tc h i
2 test. Continuous variables like
sample size and duration of follow-up was initially sum-
marized using medians and inter-quartile ranges and
later categorized as shown in Table 2. Multiple logistic
regression analysis was used to assess confounding. The
descriptive analysis was conducted using Stata version 8
(StataCorp LP, College Station, Texas, USA).
Meta-analysis
We conducted meta-analyses of summary statistics from
individual studies that compared circulating ghrelin
levels between Hp y l o r ipositive and Hp y l o r inegative
subjects; and for studies that compared circulating ghre-
lin levels before and after eradication of Hp y l o r i . For
each study, the mean circulating ghrelin concentrations
and standard deviations (sd) for the different compari-
son groups were used to generate standardized mean
differences (SMDs) and 95% confidence intervals (95%
CI) since different studies used different units to mea-
sure ghrelin concentration, and some studies measured
plasma ghrelin while others measured serum ghrelin.
For studies that reported standard errors of mean, stan-
dard deviation was derived using the formula provided
in the Cochrane Handbook of clinical reviews: SD =
SEM × √N (http://www3.interscience.wiley.com/home-
pages/106568753/handbook.pdf). Studies that reported
only medians and 95% CI or interquartile ranges
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Page 2 of 18(IQR) [2,6] were not included in the meta-analysis.
Table 4 lists studies excluded from the meta-analysis
and the reasons for their exclusion.
Study specific estimates were combined using the
inverse variance method with weighted average for con-
tinuous outcomes in a random effects model. Heteroge-
neity was assessed using the chi-squared method and
the I
2 method described by Higgins et al [28,29]. For
s t u d i e st h a tr e p o r t e dd i f f e rent sub-groups separately
[30-32] those sub-groups were included as separate
papers in the meta-analysis. Chuang et al, [30] reported
ghrelin levels for males and females separately. While
t h ed a t af o rm a l e sd i dn o ti n c r e a s et h eh e t e r o g e n e i t yo f
the studies, inclusion of the data for females introduced
significant heterogeneity to the analysis. All the papers
that resulted in significant heterogeneity of the studies
in the meta-analysis were removed from the meta-
analysis. A separate meta-analysis conducted for this
sub-group of excluded studies revealed a significant het-
erogeneity (P=0.0001; I
2 = 86%) and the effect size was
very small and not significant (SMD -0.13 [-0.33, 0.06],
Test for overall effect: Z = 1.36 (P = 0.17)). These
papers were therefore completely excluded from the
meta-analysis and described in a narrative. Sensitivity
analysis was conducted to assess the contribution of
each study to the pooled estimate by excluding indivi-
dual studies one at a time and recalculating the pooled
SMD estimates for the remaining studies. Funnel plots
were used initially to assess publication bias and later
confirmed using Begg’s and Egger’s tests. The meta-ana-
lyses were conducted using Review Manager Version 5
(RevMan 5; http://www.cc-ims.net/revman/download),
while the Begg’sa n dE g g e r ’s tests were conducted using
Stata version 8 after downloading the installation files
for the tests from the internet.
Results
Search results
The literature search yielded 1361 papers (404 from
databases and 957 from Google Scholar) plus one
unpublished paper. After removing duplicate articles,
reviews, commentaries and letters (written in response
to published articles), 166 papers (including one confer-
ence abstract and one unpublished paper) were left.
These were further screened using titles and abstract to
assess for eligibility, resulting in the exclusion of 106
articles (Figure 1). The full texts of the remaining 60
articles (excluding the conference abstract) were
Table 1 Research questions explored by the review
Research question Explanatory data
Is H pylori infection associated with circulating ghrelin levels? Data comparing circulating ghrelin concentration in H pylori positive and
negative subjects
What is the effect of eradicating H pylori on circulating ghrelin
levels?
Data comparing the circulating ghrelin concentration before and after H pylori
eradication
What is the effect of H pylori infection on ghrelin expression in the
stomach?
Data assessing any of the gastric ghrelin parameters
Table 2 Dictionary of variables used in the review
Variable Coding scheme
Study Team A, B, C etc
Design Cohort, Cross-sectional, Case control, Experimental
Healthy Healthy only, Sick only, Both
Region Asia, Africa, Europe, North America, South America
Gender Male only, Female only, Both
Age Children only, Adults only, Both
Number of methods used to assess H pylori One method; two or more methods
Type of ghrelin assay used Commercial RIA, in-house RIA, Commercial ELISA, Commercial EIA
Sample storage -70°C and below; above -70°C
Sample type Serum; Plasma
Weight Normal, Low, Various, High
Difference in circulating ghrelin concentration between H pylori
+ & - subjects
Lower, no difference, higher
Changes in circulating ghrelin after cure Increased, decreased, no change
Duration of follow-up 4 weeks & below; Above 4 weeks
Sample size Two categorizations were done: 1) 50 & below, 51-200, 201 and above;
2) Above 20, Below 20
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d r o p p e df r o mt h er e v i e w( T a b l e3 ) ,a n da n o t h e r1 1
from the meta-analysis (Table 4).
Is H pylori infection associated with circulating ghrelin
levels?
Table 5 is an evidence table of studies that compared
circulating ghrelin levels in Hp y l o r ipositive and
Hp y l o r inegative individuals. Twenty-six studies
compared circulating ghrelin levels between Hp y l o r i
positive and negative subjects. The analysis of one of
the studies [30] was stratified by gender, yielding differ-
ent results; this study was therefore entered into the evi-
dence table as two separate papers with each gender
representing one paper, bringing the total number of
papers reviewed to 27. One paper [22] was not included
i nt h ee v i d e n c et a b l eb e c a u s et h eg r o u p i n go ft h e
s u b j e c t ss t u d i e dd i dn o tp e r m i tas t r a i g h tf o r w a r d
Table 3 Papers excluded from the review
Reason for exclusion
Suzuki et al, 2006 [54] Did not report ghrelin levels in H pylori positive & H pylori negative patients
Nunes et al, 2006 [27] Not sufficient information in abstract and authors could not be contacted for further clarifications
Campana et al, 2007 [56] All subjects were H pylori negative
Isomoto et al, 2005 [52] Compared only H pylori strains
Checchi et al, 2007 [10] Did not compare serum ghrelin levels in H pylori positive & H pylori negative subjects
Wu et al, 2005 [57] Did not assess ghrelin
Shinomiya et al, 2005 [58] Did not compare the difference in ghrelin between H pylori positive & H pylori negative subjects
Suzuki et al, 2005 [59] Did not assess ghrelin
Sundbom et al, 2007 [60] Did not assess H pylori
Huang et al, 2007 [61] Did not assess H pylori
Nishizawa et al, 2006 [62] Did not assess H pylori
Ando et al, 2006 [63] Did not assess ghrelin
Kempa et al, 2007 [64] All subjects were H pylori negative
Ates et al, 2008 [65] Did not assess H pylori
Wang et al, 2006 [66] Did not assess ghrelin
Doki et al, 2006 [67] Did not assess H pylori
Gao et al, 2008 [68] Excluded people with H pylori
Cherian et al, 2009 [69] Did not assess ghrelin
Kebapcilar et al, 2009 [70] Did not assess ghrelin
Dutta et al, 2009 [71] Did not assess ghrelin
Gen et al, 2010 [72] Did not assess ghrelin
Taniaka-Shintani et al, 2005 [1] Examined only ghrelin immunoreactive cells
Table 4 Papers excluded from the meta-analysis
Nwokolo et al, 2003 [2] Reported median values & 95% CI; also measured integrated ghrelin levels rather than the discrete measurement that
other authors used. The authors stated that the median values were used because the sample size was small and the
data were skewed
Mendez-Sanchez et al,
2007 [49]
Studied ghrelin immuno-reactive cells, did not provide data on plasma ghrelin levels
Salles et al, 2006 [19] Ghrelin values not provided. Only P-values
Gao et al, 2009 [15] Ghrelin values not provided
Choe et al, 2007 [6] Median & IQR provided. Further clarifications not provided by the authors
Czesnikiewicz-Guzik et al,
2005 [12]
Insufficient information for meta-analysis
Czesnikiewicz-Guzik et al,
2007 [13]
Insufficient information for meta-analysis
Masaoka et al [51] This was a case study with only one subject
Stec-Michalska et al,
2009 [24]
Measured only gastric ghrelin
Liew et al, 2006 [47] Assessed only gastric ghrelin
Konturek et al, 2006 [17] The numbers of H pylori positive and negative participants were not provided and the authors did not respond to
requests for further information.
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tive subjects. The paper was therefore reviewed in a
separate narrative. Table 6 summarises the characteris-
tics of the studies included in the evidence table. Most
of the studies (77%) investigated both males and
females, 85% studied only adults and 52% studied sick
subjects mainly subjects with gastrointestinal symptoms
(64.7%) and Cancer (17.65%). Thirteen (48.2%) of the
studies [15,21,30,33-41] were conducted in Asia; 11
(40.7%) [3,11,12,17,19,26,31, 32,42-44] in Europe and
three (11.1%) [14,18,45] in North America. Twenty-two
percent of the studies reviewed were contributed by one
research group alone, while Japan contributed 30% of
the papers. More than two-thirds of the studies used
radioimmunoassay to measure serum or plasma ghrelin,
55.6% assessed Hp y l o r iusing two or more methods,
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Figure 1 PRISMA flow chart showing information flow in the selection of papers for the review.
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Page 5 of 18Table 5 Evidence table of studies that compared circulating ghrelin levels in Hp+ and Hp- individuals
Reference & Country Study
Team
Design Healthy Gender Age Method of H pylori
assessment
Ghrelin
assay kit
Overnight
fast
Sample
storage
Sample
type
Weight Sample
size
Ghrelin levels in
Hp+ vs Hp-
Kawashima et al, 2009;
Japan [38]
A Cohort Both Both Adults Serology Commercial
EIA
Yes -80 Plasma Normal 220 Lower
Plonka et al, 2006;
Poland [32]
B Cohort Healthy Both Both Modified UBT plus ELISA Commercial
RIA
Yes -80 Serum 538 Lower
Isomoto et al, 2005;
Japan [36]
C Cohort Sick Both Adults RUT, histology (Giemsa
stain)
In-house RIA Yes -80 Plasma Normal 81 Lower
Roper et al, 2008;
USA [18]
D Cross-
sectional
Healthy Men Adults serology, histology & RUT or
positive culture
Commercial
EIA
Yes -20 Serum Normal 256 No Difference
Pacifico et al, 2008;
Italy [26]
E Cohort Both Both Children Culture of gastric specimen
or histology + RUT
Commercial
RIA
Yes -70 Serum Normal 85 No Difference
Gokcel, 2003; Turkey [3] F Case
control
Sick Women Adults Not stated Commercial
EIA
Yes Not
stated
Plasma Normal 39 No Difference
Plonka et al, 2006;
Poland [43]
B Case
control
Healthy Both Children Serology and UBT Commercial
RIA
Yes -80 Serum Various 287 Lower
Shiotani et al, 2005;
Japan [21]
G Case
control
Healthy Both Adults Detection of HP IgG ab in
the urine
Commercial
ELISA
Yes Not
stated
Serum Various 132 Lower
Osawa et al, 2005;
Japan [40]
C Case
control
Sick Men Adults Culture & histology In-house RIA Yes -30 Plasma Normal 160 Lower
Chuang et al*, 2009;
Taiwan [30]
H Cross-
sectional
Sick Men Adults Not described Commercial
RIA
Yes -72 Plasma low to
normal
145 Lower
Chuang et al*, 2009;
Taiwan [30]
H Cross-
sectional
Sick Women Adults Not described Commercial
RIA
Yes -72 Plasma low to
normal
196 No Difference
Alonso et al, 2007;
Spain [42]
P Cross-
sectional
Sick Both Adults UBT, histology (Giemsa
stain)
Commercial
RIA
Yes -80 Plasma Normal 15 Lower
Salles et al, 2006;
France [19]
I Cross-
sectional
Sick Both Adults UBT, serology, culture,
histology & PCR
Commercial
RIA
Yes -80 Plasma low to
normal
62 Lower
Jun et al, 2007; Korea [37] J Cross-
sectional
Sick Both Adults RUT, histology (Giemsa
stain)
Commercial
RIA
Yes -70 Plasma Normal 63 No Difference
D’Onghia et al, 2007;
Italy [31]
K Case
control
Both Both Adults ELISA RIA Yes -20 Serum Various 79 Lower
Gao et al, 2009;
China [15]
L Case
control
Healthy Both Adults Serology & UBT. Commercial
RIA
Yes -80 Plasma Normal 100 Lower
Isomoto et al, 2005;
Japan [35]
C Cross-
sectional
Sick Both Adults Anti-IgG antibody, 13C-UBT,
or RUT
In-house RIA Yes -80 Plasma Normal 89 Lower
Isomoto et al, 2005;
Japan [41]
C Cross-
sectional
Sick Both Adults Serology, UBT or RUT In-house RIA Yes -80 Plasma Normal 249 Lower
An et al, 2007; Korea [33] Q Cohort Sick Both Adults Not stated Commercial
ELISA
Yes -70 Plasma Normal 41 No difference
Nishi et al, 2005;
Japan [39]
C Cross-
sectional
Both Both Adults Serology & UBT In-house RIA Yes -80 Plasma Normal 74 Lower
Czesnikiewicz-Guzik et al,
2005; Poland [12]
B Cross-
sectional
Healthy Women Adults UBT Not stated Not stated Not
stated
Serum Not
Stated
100 Lower
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8Table 5 Evidence table of studies that compared circulating ghrelin levels in Hp+ and Hp- individuals (Continued)
Konturek et al, 2006;
Poland [17]
B Cross-
sectional
Healthy Both Both UBT & serology Human RIA Yes -80 Serum Not
Stated
180 Lower
Cindoruk et al, 2007;
Turkey [11]
M Cohort Sick Both Adults Either histology or UBT RIA Yes -80 Plasma Normal 50 No Difference
Isomoto et al, 2004;
Japan [34]
C Cohort Sick Both Adults Serology Commercial
RIA
Yes -80 Plasma Normal 68 Lower
de Martel, 2007; USA [14] N Case
control
Sick Both Adults In-house ELISA Commercial
ELISA
Yes -80 Serum Various 110 No Difference
Shak et al, 2008, USA [45] R Cohort Healthy Both Adults Serology Commercial
EIA
Yes -20 Plasma Obese 24 No difference
Uzzan et al, 2007 [44] S Cohort Healthy Both Adults Histology Commercial
RIA
Yes Not
stated
Serum Obese 13 No difference
* These are from the same paper reporting the same study but were separated because the analysis was stratified by gender and the results for males and females were completely different; hence the decision to
separate them.
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8and in all the studies except one, samples were collected
after overnight fast. All comparisons were based on the
pre-meal ghrelin levels. In most of the studies (70.4%),
the samples were stored at a temperature of -70°C or
below until analysed; ghrelin was measure in plasma
samples in 63% of the studies, while the participants were
of normal weight in 58% of the studies. The sample sizes
for the different studies ranged from 13 to 538 (median:
89; IQR: 62, 180).
Overall, 17 studies (63%) reported that circulating
ghrelin concentrations were lower in Hp y l o r ipositive
subjects. Ten studies from Asia (76.9%) and seven from
Europe (63.6%) found that circulating ghrelin levels
in Hp y l o r ipositive subjects were lower compared to
Hp y l o r inegative subjects. The rest of the studies,
including the three from the USA did not find any dif-
ference between Hp y l o r ipositive and negative subjects.
There was a weak association between the region of the
world where the study was conducted and the finding of
a lower circulating ghrelin level in H pylori positive sub-
jects compared to Hp y l o r inegative subjects (Fisher’s
exact test = 0.07). This completely disappeared after
controlling for gender, age, health status, type of sample
used, storage conditions, BMI, and the sample size.
Zub-Pokrowiecka et al [22] investigated ghrelin
changes in the plasma and gastric mucosa among parti-
cipants with various gastric diseases. Their subjects were
divided into four groups - Group 1 had gastric cancer
and concomitant H pylori infection; group 2 had antral
gastritis, duodenal ulcer and H pylori infection; group 3
had atrophic gastritis of the fundus and corpus of the
stomach but no Hp y l o r iinfection; while group 4 had
no gastric lesions and no Hp y l o r iinfection. These
researchers reported that the fasting plasma ghrelin con-
centrations varied among the different groups as follows
(in descending order): group 2, group 4, group 1 and
group 3.
Meta-analysis
Twenty-one of the 26 studies reviewed in this section
qualified for inclusion in the meta-analysis. Of these 21
studies, three studies provided ghrelin values for the dif-
ferent categories of subjects studied. Chuang et al [30]
presented their results by gender; D’Onghia et al [31]
presented their results according to whether the subjects
were healthy controls or had colo-rectal cancer; and
Plonka et al [32] presented their results for adults and
children separately. Because each of these features could
affect the circulating ghrelin concentration, the different
categories were entered into the meta-analysis as sepa-
rate papers bringing the total number of papers included
to 24 with a total of 2244 participants. Table 4 lists stu-
dies excluded from the meta-analysis. Four papers were
subsequently removed from the final analysis because
they added significant heterogeneity to the analysis
Table 6 Summary of the characteristics of the studies
reviewed in Table 5
Characteristic n n %
Study Design Case control 7 25.93
Cohort 9 33.33
Cross-sectional 11 40.74
Gender studied Both 21 77.78
Men 3 11.11
Women 3 11.11
Region Asia 13 48.15
Europe 11 40.74
North America 3 11.11
Health status Both 4 14.81
Healthy 9 33.33
Sick 14 51.85
Age Group Adults 23 85.19
Both 2 7.41
Children 2 7.41
Type of Sickness Cancer 3 17.65
GI symptoms 11 64.71
Others† 3 17.64
HP assessment methods used Not Described 5 18.52
One 7 25.93
Two or more 15 55.56
Assay Type Commercial EIA 4 14.81
Commercial ELISA 3 11.11
Commercial RIA 14 51.85
In-house RIA 5 18.52
Not stated 1 3.7
Sample Size 50 and below 6 22.22
51-200 16 59.26
201 and above 5 18.52
Sample Storage -70C and above 19 70.37
Below -70C 4 14.81
Not Described 4 14.81
Sample type Plasma 17 62.96
Serum 10 37.04
BMI of participants Normal 15 57.69
Not Stated 2 7.69
Obese 2 7.69
Various 4 15.38
low to normal 3 11.54
†Others include Crohn’s disease (1), diabetes mellitus (1) and multiple conditions (1).
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Page 8 of 18(Figure 2). The analysis showed that circulating ghrelin
concentration was significantly lower in H pylori positive
participants than in H pylori negative participants (Effect
estimate (95%CI) = -0.48 [-0.60, -0.36]). Figure 2 is a
forest plot of SMDs of circulating ghrelin concentration
between H pylori positive and H pylori negative subjects.
There was no significant heterogeneity among the stu-
dies (Heterogeneity: Chi² = 24.21, df = 19 (P = 0.19);
I² = 22%). Examination of the funnel plot (Figure 3) sug-
gests some publication bias but the Egger and Begg’s
tests indicated no publication bias (Begg’s test: z = 1.20
(continuity corrected), P = 0.23 (continuity corrected);
Egger’s bias coefficient = -59.99, P = 0.116). A sensitivity
analysis indicated that all the studies included in the
meta-analysis contributed approximately equally to the
pooled estimate (Table 7). Three of the studies dropped
from the meta-analysis did not find any difference in the
circulating ghrelin levels between Hp y l o r ipositive and
H pylori negative subjects [14,26,30]. However, Plonka et
al [32] found a significantly lower circulating ghrelin
levels among a group of Hp y l o r ipositive Polish shep-
herds compared to their H pylori negative controls. Add-
ing these four papers (excluded because of heterogeneity)
only slightly increased the effect estimate (-0.42 [-0.57,
-0.27]) but still showed that H pylori infection was asso-
ciated with a lower circulating ghrelin concentration.
What is the effect of eradicating H pylori on circulating
ghrelin levels?
Table 8 presents an evidence table of the studies that
reported the effect of eradicating H pylori on circulating
ghrelin levels. Thirteen papers were reviewed 12 of
which were cohort studies and one RCT. Five of the 13
studies were conducted in Japan; 3 in Korea (both in
Asia) and four in Europe. The only study from Africa
was an unpublished paper by our team. Table 9 is a
summary of the characteristics of the studies in Table 8.
In 11 studies, the subjects fasted overnight, and for 3
hours (between 6am and 9am) in one study, before
being bled. Osawa et al [46] did not indicate whether
their subjects were fasted or not. The sample sizes var-
ied from 3 to 134; median value was 16 (IQR: 9, 43).
The duration of follow-up varied from 4 weeks to 52
weeks (median follow-up time: 4.5 weeks; IQR: 4 weeks,
12 weeks). Jang et al [16] were not clear on the duration
of follow-up of their subjects.
Figure 2 Forest plot of SMDs of circulating ghrelin concentration between H pylori positive and H pylori negative subjects (the top
forest plot labelled ‘actual’ represents the analysis on which the inference was made. The lower forest plot labelled ‘removed’ were
studies excluded from the meta-analysis but displayed here to demonstrate their characteristics for readers that might be interested. The values
at the bottom of the forest plot represents the overall effect size for both the ‘actual’ and the ‘removed’.
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Page 9 of 18In seven studies (53.9%) there was no significant dif-
ference in circulating ghrelin levels pre- and post H
pylori eradication. Three studies (23.1%) reported an
increase above the pre-eradication level while 3 (23.1%)
reported a decrease below the pre-eradication levels.
Cross tabulation of the following variables with change
in circulating ghrelin levels following cure of Hp y l o r i
infection did not show any association: the age of the
participants, the type of sample used, duration of fol-
low-up, sample size, weight of participants, temperature
at which the blood samples were stored, the assay kit
used to measure circulating ghrelin, the number of
methods used to assess Hp y l o r i , gender, country and
the region where the study was conducted. Although
not statistically significant, the circulating ghrelin con-
centration decreased following Hp y l o r ieradication in
the two studies that measured ghrelin using serum sam-
ples (Fisher’s exact test 0.08). Similarly, the two studies
c o n d u c t e do nc h i l d r e nf o u nd a decrease in circulating
ghrelin levels after Hp y l o r icure. However, these two
studies on children also utilised serum samples; while all
the 11 studies conducted in adults used plasma samples.
From this descriptive analysis, there is not sufficient
data to make a conclusive statement on the effect of
H pylori eradication on circulating ghrelin levels.
Meta-analysis
Nine (out of the 13 studies reviewed in this section)
were included in a meta-analysis with a total population
of 592. The excluded studies are listed in Table 4. The
analysis showed that eradicating H pylori does not have
any significant effect on circulating ghrelin levels (Effect
estimate (95% CI) = -0.08 [-0.33, 0.16]; Test for overall
effect: Z = 0.67 (P = 0.5)). Figure 4 is a forest plot of
SMDs of circulating ghrelin concentration pre- and
post-eradication of Hp y l o r i . The funnel plot indicated
publication bias (Figure 5).
What is the effect of H pylori infection on ghrelin
expression in the stomach?
Thirteen studies examined the effects of Hp y l o r iinfec-
tion on gastric ghrelin. This includes six cohort studies
[6,36,44,46-48], 2 case-control studies [40,49], four
cross-sectional studies [18,19,24,37] and one randomised
controlled trial [23]. The participants included sick sub-
jects (7), well subjects (3) and both well and sick sub-
jects (2). Eight studies were conducted in Asia, two in
Figure 3 Funnel plot of SMDs of circulating ghrelin concentration between H pylori positive and H pylori negative subjects.
Nweneka and Prentice BMC Gastroenterology 2011, 11:7
http://www.biomedcentral.com/1471-230X/11/7
Page 10 of 18France, one each in Poland, Brazil and USA. Ten studies
recruited both males and females, and three recruited
males only. All the sick participants had gastrointestinal
symptoms. Different methods were used to assess H
pylori infection either alone or in combination: histology
(11 studies), culture (3), rapid urease assay (5), serology
(3), urea breath test (2) and PCR (4). Ten of the 13 stu-
dies were conducted on normal weight subjects, two on
obese subjects and one on subjects of different body
weights. Due to the different gastric ghrelin parameters
assessed, a meta-analysis was not possible.
Five studies assessed gastric ghrelin contents: one
f o u n di tt ob el o w e ri nHp y l o r ipositive subjects [36],
three [6,18,44] found no significant difference between
H pylori positive and negative participants, and one [24]
found increased levels in H pylori positive participants.
Isomoto et al [36] compared gastric ghrelin peptide con-
tents in the endoscopic biopsies from the corpus of 56
H pylori positive and 25 H pylori negative subjects using
radio-immunoassay. They reported significantly lower
gastric ghrelin content in the H pylori positive subjects
than the H pylori negative subjects. Roper et al [18] stu-
died 216 adult males of normal BMI presenting for rou-
tine endoscopy consisting of 120 Hp y l o r ipositive and
96 Hp y l o r inegative subjects. Although they did not
find any significant differen c ei nt h eg a s t r i cg h r e l i n
levels between Hp y l o r ipositive and Hp y l o r inegative
subjects, they reported a very wide variation in the con-
centration of ghrelin in the gastric juice (from <80 to
776,000 pg/ml) with the H pylori positive subjects hav-
ing higher gastric juice ghrelin levels than the Hp y l o r i
negative subjects. Choe et al [6] did not find any signifi-
cant difference in the gastric ghrelin levels between
Hp y l o r ipositive and Hp y l o r inegative subjects using
biopsied tissues.
Four studies examined the expression of ghrelin
mRNA in gastric mucosa [19,36,37,40]. Three studies
found ghrelin mRNA expression to be lower in H pylori
positive subjects than in Hp y l o r inegative subjects,
while Jun et al [37] found no difference. Five studies
assessed the quantity of ghrelin immunoreactive cells in
the gastric mucosa [36,40,47-49]; all of which found that
Hp y l o r ipositive subjects had fewer ghrelin-producing
cells than in uninfected subjects. However, in the study
by Isomoto et al [36], this difference did not achieve sta-
tistical significance.
Five studies compared the various gastric ghrelin para-
meters before and after Hp y l o r ieradication [6,23,36,
46,48]. Choe et al [6] did not find any significant differ-
ence in the ghrelin concentration in the antrum, corpus
and fundus pre- and post- Hp y l o r ieradication. Lee
et al [23] reported a randomized controlled trial on
H pylori positive volunteers without peptic ulcer or any
other gastrointestinal symptoms in which the treatment
group received triple H pylori eradication regimen while
the control group did not receive any treatment. These
authors reported a significant increase in gastric ghrelin
mRNA expression following eradication compared to
Table 7 Sensitivity analysis of studies included in the meta-analysis
Studies excluded SMD (95%CI) Test for overall effect
Alonso et al, 2007 -0.47 [-0.59, -0.35] Z = 7.80 (P < 0.00001)
An et al, 2007 -0.49 [-0.61, -0.37] Z = 7.88 (P < 0.00001)
Chuang et al_male, 2009 -0.48 [-0.61, -0.35] Z = 7.39 (P < 0.00001)
Cindoruk et al, 2007 -0.49 [-0.61, -0.38] Z = 8.48 (P < 0.00001)
D’Onghia et al_case, 2007 -0.47 [-0.60, -0.35] Z = 7.64 (P < 0.00001)
D’Onghia et al_control, 2007 -0.49 [-0.61, -0.37] Z = 7.95 (P < 0.00001)
Gokcel et al, 2003 -0.49 [-0.61, -0.36] Z = 7.84 (P < 0.00001)
Isomoto et al, 2004 -0.46 [-0.57, -0.35] Z = 7.96 (P < 0.00001)
Isomoto et al, 2005a -0.47 [-0.60, -0.35] Z = 7.47 (P < 0.00001)
Isomoto et al, 2005b -0.47 [-0.59, -0.34] Z = 7.43 (P < 0.00001)
Isomoto et al, 2005c -0.48 [-0.61, -0.35] Z = 7.14 (P < 0.00001)
Jun et al, 2007 -0.49 [-0.61, -0.36] Z = 7.72 (P < 0.00001)
Kawashima et al, 2009 -0.48 [-0.61, -0.35] Z = 7.32 (P < 0.00001)
Nishi et al, 2005 -0.49 [-0.59, -0.39] Z = 9.72 (P < 0.00001)
Osawa et al, 2005 -0.46 [-0.58, -0.34] Z = 7.45 (P < 0.00001)
Plonka et al_ch1 2006 -0.46 [-0.58, -0.34] Z = 7.65 (P < 0.00001)
Roper et al, 2008 -0.51 [-0.63, -0.39] Z = 8.37 (P < 0.00001)
Shak et al, 2008 -0.48 [-0.60, -0.36] Z = 7.79 (P < 0.00001)
Shiotani et al, 2005 -0.46 [-0.59, -0.34] Z = 7.33 (P < 0.00001)
Uzzan et al, 2007 -0.47 [-0.59, -0.35] Z = 7.76 (P < 0.00001)
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Page 11 of 18Table 8 Evidence table of studies that examined changes in circulating ghrelin levels following H pylori eradication
Reference & Country Study
Team
Design Healthy Gender Age
category
HP assess Ghrelin
assay Kit
Sample
storage
Sample
type
Weight Sample
size
Circulating Ghrelin
levels after cure
Follow-
up (wks)
Nwokolo et al, 2003;
UK [2]
A Cohort Healthy Both Adults Serology and UBT Commercial
RIA
-20 Plasma Various 10 Increased 6
Jang et al, 2008; Korea
[16]
B Cohort Sick Both Adults RUT plus histology & confirmed
by UBT
Commercial
RIA
-70 Plasma Normal 16 Increased Not
stated
Osawa et al, 2006;
Japan [46]
C Cohort Healthy Men Adults Bacterial culture & histology In-house RIA Not
stated
Plasma Normal 134 Decreased 12
Czesnikiewicz-Guzik et
al, 2007; Poland [13]
D Cohort Sick Women Adults UBT; culture of saliva &
supragingival dental plaques +
serology
Commercial
RIA
-80 Plasma Not
stated
49 Increased 4
Lee et al, 2010; Korea
[23]
B RCT Healthy Both Adults RUT, histology (Giemsa stain) ELISA -70 Plasma Normal 9 No difference 5
Choe et al, 2007, Korea
[6]
E Cohort Sick Both Adults histology & PCR Commercial
ELISA
-70 Plasma Normal 8 No difference 4
Pacifico et al, 2008;
Italy [26]
F Cohort Both Both Children Culture of gastric specimen or
histology + RUT
RIA -70 Serum Normal 22 Decreased 52
Nweneka, et al,
unpublished; Gambia
G Cohort Sick Both Children UBT Commercial
RIA
-70 Serum Low 3 Decreased 4
Isomoto et al, 2005;
Japan [36]
C Cohort Sick Both Adults RUT, histology (Giemsa stain) In-house RIA -80 Plasma Normal 43 No difference 4
Isomoto et al, 2005;
Japan[35]
C Cohort Sick Both Adults RUT, histology (Giemsa stain) In-house RIA -80 Plasma Normal 10 No difference 4
Kawashima et al, 2009;
Japan [38]
H Cohort Both Both Adults Serology Commercial
EIA
-80 Plasma Normal 49 Increased 23
Cindoruk et al, 2007;
Turkey [11]
I Cohort Sick Both Adults Either histology or UBT RIA -80 Plasma Normal 23 No difference 12
Isomoto et al, 2004;
Japan [34]
C Cohort Sick Both Adults Serology Commercial
RIA
-80 Plasma Normal 9 No difference 4
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8the control group. Osawa et al [46] also reported an
increase in ghrelin mRNA expression following H pylori
cure. Although Isomoto et al [36] found a tendency
towards increase in ghrelin mRNA expression following
cure of H pylori, this increase was not significant. Tatsu-
guchi et al [48], on the other hand, found an increase in
ghrelin immunoreactive cells following H pylori eradica-
tion in 50 patients with either peptic ulcer disease or
gastritis, while in 11 patients who did not respond to
eradication therapy, there was no difference in the num-
ber of ghrelin immunoreactive cells pre-and post-eradi-
cation therapy.
Three studies [36,47,49] found a negative correlation
between ghrelin producing cells in the gastrum and the
severity of Hp y l o r iinfection. Gastric ghrelin content
and gastric ghrelin mRNA expression were both posi-
tively correlated with plasma ghrelin concentration
[36,46].
Discussion
The potential role of ghrelin in body mass regulation
makes understanding its interactions with Helicobacter
pylori, a highly prevalent gastrointestinal infection,
important. To address this issue, we asked three ques-
tions: how does Hp y l o r iinfection affect circulating
ghrelin levels; how does eradicating Hp y l o r iaffect cir-
culating ghrelin; and how does Hp y l o r iinfection affect
gastric ghrelin and ghrelin producing cells.
The results of our analysis has conclusively shown that
circulating ghrelin levels are significantly higher in
Hp y l o r inegative people than in those infected with
H pylori (P = 0.00001). Our results also suggest that era-
dicating H pylori does not have any significant effect on
circulating ghrelin. Although there was no significant
heterogeneity between the group of studies that com-
pared circulating ghrelin concentrations before and after
Hp y l o r ieradication, this result should be interpreted
with the following caveats in mind: 1) three of the stu-
dies [34-36] included in the meta-analysis came from
the same research group; and together accounted for
29% of the effect size; 2) the paper by Osawa et al [46]
which reported higher ghrelin levels before H pylori era-
dication compared to the levels after eradication on its
own contributed 26.2% of the effect; and 3) the sample
sizes of most of the other studies were relatively small.
Interestingly, all the smaller studies, except one, found
higher circulating ghrelin levels post-eradication. Even
among the subjects studied by Osawa et al [46], plasma
ghrelin increased in 50 patients and decreased in 84
patients, although the overall effect was a decrease post-
eradication. They were however, able to show that pre-
eradication elevation of ghrelin was associated with a
Table 9 Summary of the characteristics of the studies
reviewed in Table 8
Characteristic n %
Study Design Cohort 12 92.31
RCT 1 7.69
Gender studied Both 11 84.62
Men 1 7.69
Women 1 7.69
Region Africa 1 7.69
Asia 8 61.54
Europe 4 30.77
Health status Both 2 15.38
Healthy 3 23.08
Sick 8 61.54
Age Group Adults 11 84.62
Children 2 15.38
Type of Sickness GI Symptoms 9 90
PEM 1 10
HP assessment methods used One 3 23.08
Two or more 10 76.92
Assay Type ELISA 2 15.38
Commercial RIA 8 61.54
In-house RIA 3 23.08
Sample Size Above 20 6 46.15
Below 20 7 53.85
Sample Storage -70°C and below 11 84.62
Above -70°C 1 7.69
Not described 1 7.69
Sample type Plasma 11 84.62
Serum 2 15.38
BMI of participants Normal 10 76.92
Others 3 23.07
Duration of follow-up 4 weeks & below 6 46.15
Above 4 weeks 6 46.15
Not recorded 1 7.69
Change in ghrelin after cure Decreased 3 23.08
Increased 3 23.08
No difference 7 53.85
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Page 13 of 18fall in ghrelin post-eradication. In our unpublished data,
we also found that elevated ghrelin concentration pre-
eradication was associated with a fall post-eradication.
These two observations suggest that in addition to other
factors, the pre-eradication ghrelin level determines the
direction of response of ghrelin post-eradication.
The heterogeneity of the studies examining the effect
of Hp y l o r ion gastric ghrelin expression as well as the
small number of studies that examined different aspects
of this relationship did not allow a meta-analysis to be
performed. However, the descriptive data suggests that
available evidence is still discrepant; although the weight
of evidence seems to favour lower ghrelin mRNA and
ghrelin immunoreactive cells in association with
Hp y l o r iinfection [19,36,40,47-49]. The ultimate effect
of Hp y l o r ion gastric ghrelin appears to be dependent
on the duration of infection and the extent of Hp y l o r i -
induced damage to the gastric mucosa. At least three
Figure 4 Forest plot of SMDs of circulating ghrelin concentration pre- and post- eradication of H pylori.
Figure 5 Funnel plot of SMDs of circulating ghrelin concentration pre- and post- eradication of H pylori.
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Page 14 of 18studies found a negative correlation between number of
ghrelin producing cells and the severity of Hp y l o r i
infection [36,47,49].
The close anatomical proximity between the site of
Hp y l o r iinfection and the site of ghrelin production
m i g h tr e s u l ti nt h el o s so fghrelin producing cells as
part of the H pylori associated gastritis, causing reduced
ghrelin production. However, such effect will not be
restricted to Hp y l o r iinfection and could occur in any
other condition associated with gastritis. For example,
Checchi et al [10] studied 233 patients with autoim-
mune gastritis (indicated by elevated parietal cell anti-
body (PCA)) and 211 control subjects, and found that
mean serum ghrelin levels in PCA positive patients were
significantly lower than in PCA negative patients, similar
to the results found in Hp y l o r iinfection by some stu-
dies. This decrease remained significant even after
excluding patients with Hp y l o r iinfection, suggesting
that the Hp y l o r iinfection was not necessarily responsi-
ble for the reduction in serum ghrelin. Again, the region
of the stomach biopsied could also affect the results.
Jang et al [16] reported that after ulcer healing and
H pylori eradication, there was a significant increase in
the levels of ghrelin mRNA. But while corpus ghrelin
mRNA increased after cure and Hp y l o r ieradication,
anthral ghrelin mRNA decreased, suggesting a differen-
tial response by the ghrelin producing cells in the differ-
ent regions of the stomach. In healthy Hp y l o r iinfected
subjects however, Lee et al [23] found a significant
increase in fundic ghrelin mRNA after eradication
of Hp y l o r i(P = 0.0002) but no change in the anthral
ghrelin mRNA (P = 0.5), suggesting a more complex
relationship between gastric ghrelin production and
Hp y l o r iinfection. Teasing out this relationship will
require more rigorous investigation.
If H pylori infection is associated with a lower circu-
lating ghrelin, it is biologically plausible that its eradi-
cation will be associated with an increase in circulating
ghrelin. But if Hp y l o r ireduces circulating ghrelin by
destroying ghrelin producing cells, then the effect of
eradicating it on circulating ghrelin would depend on
the duration of infection, the amount of damage to
ghrelin-producing cells, and the time it takes for these
cells to regenerate. Indeed several studies have found a
negative correlation between the number of ghrelin
producing cells and the severity of gastritis [36,47,49].
And in one study, there was no change in ghrelin
levels post-eradication after 4 weeks of follow-up, but
the level progressively increased with follow-up,
achieving, in some subjects, significant increase after 6
months of follow-up [36]. In contrast, mice infected
with Hp y l o r ifor 6-8 months had higher ghrelin levels
compared to time-matched controls, which normalised
two months post-eradication [50]. However, Masaoka
et al [51] did not find any change in circulating ghrelin
levels 2 years after successful eradication of Hp y l o r iin
an adult man.
The discrepancy in the response to Hp y l o r ieradica-
tion could also be related to the strain of Hp y l o r i .I s o -
moto et al [52] found that strain diversity in Hp y l o r i
was associated with plasma and gastric ghrelin levels in
humans. Patients with type I strain (which express the
virulence factors cytotoxin-associated gene product
(CagA) and Vacuolating cytotoxin A (VacA)) have lower
circulating ghrelin levels than those with the less viru-
lent type II strain which does not express the virulence
factors. This finding also argues for a possible racial dif-
ference in the association between circulating ghrelin
levels and Hp y l o r iinfection: in regions where type I
strain is dominant, one would expect to see reduced cir-
culating ghrelin levels. While such speculation is attrac-
tive, it might not be entirely correct [53]. In this review,
the effect of region and country of study on the rela-
tionship between Hp y l o r iand ghrelin was very weak,
and appears to be confounded by several other factors.
The underlying clinical condition of the subject might
also be affecting the results. Suzuki et al [54] studied
plasma ghrelin in patients with peptic ulcer disease.
They found that plasma ghrelin levels were significantly
higher in patients with duodenal ulcer as well as those
with gastric ulcer compared to those with chronic gas-
tritis. Among the subjects that were Hp y l o r ipositive,
plasma ghrelin was significantly higher in patients with
duodenal or gastric ulcer than in those with non-ulcer
chronic gastritis. After treatment for the ulcer (with
healing), no significant change was found in the plasma
ghrelin levels (i.e. pre-and post eradication levels were
similar). Most of the studies reviewed here recruited
subjects with varying degrees and types of gastrointest-
inal pathology. If each of these gastrointestinal diseases
affects ghrelin production differently as suggested by
Suzuki et al [54], then the discrepancies noted in this
review are to be expected. Compensation from other
sources of ghrelin production might also explain the
various inconsistencies highlighted in this review. For
example, Suzuki et al [55] infected Mongolian gerbils
with H pylori and assessed the plasma and gastric ghre-
lin levels at 17 and 23 weeks after the infection. They
found a significant decrease in gastric ghrelin in the
Hp y l o r ipositive gerbils compared to the controls, but
also found a significant increase in plasma ghrelin levels
in the Hp y l o r ipositive group. This same group also
found increased plasma ghrelin and decreased gastric
ghrelin levels in IL-1R1 knockout mice [4] suggesting
that other sources of ghrelin might have contributed to
the increased plasma ghrelin.
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Page 15 of 18Limitations and implications for research and practice
The major limitation of this review is the use of only
English language papers, which raises the possibility of
some publication bias. Another limitation in conducting
this review is that all except one of the papers were obser-
vational studies, most of which did not primarily set out to
assess the relationship between ghrelin and H pylori;b u t
assessed both parameters in relation to other objectives.
Well designed randomised clinical trials are needed to ver-
ify the conclusions made by this review. Also, many of the
studies included participants with diverse disease condi-
tions whose impacts on ghrelin secretion have not been
investigated before. The best approach to solve the riddle
of the relationship between ghrelin and helicobacter pylori
might be to study otherwise healthy participants with
asymptomatic Hp y l o r iinfection.
Conclusions
From available evidence, circulating ghrelin concentration
is lower in people infected with Hp y l o r icompared to
those not infected with the bacterium. However, a more
complex relationship exists between circulating ghrelin
levels and eradication of Hp y l o r i . This relationship may
be modulated by the strain of infecting Hp y l o r i , the dura-
tion of follow-up, the extent of H pylori-induced gastritis
and other underlying pathology. More studies are needed
to further elucidate the impact of H pylori eradication on
circulating ghrelin concentration.
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